Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Practical steps to enhance personal finance management skills, including tracking spending, setting goals, and using budgeting tools effectively.
23,748 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Crypto traders increasingly rely on AI to sift signals and manage portfolios. This gpt-5.6 fable review: which guide ...
Jim Cramer advises investors to wait before buying Vertiv after a pronounced dip, arguing that selling pressure could...
On July 22, AI-driven hardware names moved the dial as SMCI posted a surprising margin beat and a burst of orders. Th...
Bitcoin trades within a broad range as traders watch a historic buy zone. ETF-driven liquidity and macro shifts could...
A single Vanguard mega-cap ETF has a heavy tilt toward four tech giants. This deep dive explains what that concentrat...
UnitedHealth stock has lagged in 2026, raising questions about its earnings, growth, and risks. This deep-dive breaks...
Oneok beat quarterly expectations but issued soft 2026 guidance, sending shares lower. This article explains why oneo...
ZachXBT has named Axiom in a probe over alleged insider trading by an employee. Axiom paused internal tools and says ...
Paramount has emerged as the apparent victor in a months-long bidding war to buy Warner Bros. Discovery’s film and TV...
As March unfolds, two names stand out in the evolving world of SMRs and clean power. This article breaks down why NuS...
Goldman Sachs upgrades Liberty Energy and Patterson-UTI after surprising Q4 results, highlighting a growing gap betwe...